Diagnosis and Treatment of Multiple Sclerosis: A Review.
McGinley MP, Goldschmidt CH, Rae-Grant AD.
JAMA. 2021 Feb 23;325(8):765-779. doi: 10.1001/jama.2020.26858.
Therapeutic Management During Pregnancy and Relapse Risk in Women With Multiple Sclerosis.
Gavoille A, Rollot F, Casey R, Mathey G, Le Page E, Ciron J, De Sèze J, Ruet A, Maillart E, Labauge P, Zephir H, Kwiatkowski A, Papeix C, Defer G, Lebrun-Frenay C, Moreau T, Laplaud DA, Berger E, Dubessy AL, Clavelou P, Thouvenot E, Heinzlef O, Pelletier J, Al-Khedr A, Casez O, Bourre B, Wahab A, Magy L, Moulin S, Camdessanché JP, Doghri I, Sarov-Riviere M, Hankiewicz K, Pottier C, Dos Santos A, Nifle C, Subtil F, Vukusic S; OFSEP Investigators.
JAMA Neurol. 2025 Oct 1;82(10):994-1003. doi: 10.1001/jamaneurol.2025.2550.
ECTRIMS/EAN guideline on the pharmacological treatment of people with multiple sclerosis.
Montalban X, Gold R, Thompson AJ, Otero-Romero S, Amato MP, Chandraratna D, Clanet M, Comi G, Derfuss T, Fazekas F, Hartung HP, Havrdova E, Hemmer B, Kappos L, Liblau R, Lubetzki C, Marcus E, Miller DH, Olsson T, Pilling S, Selmaj K, Siva A, Sorensen PS, Sormani MP, Thalheim C, Wiendl H, Zipp F.
Eur J Neurol. 2018 Feb;25(2):215-237. doi: 10.1111/ene.13536. Epub 2018 Jan 19.
Health benefits of combined oral contraceptives - a narrative review.
Coelingh Bennink HJT, van Gennip FAM, Gerrits MGF, Egberts JFM, Gemzell-Danielsson K, Kopp-Kallner H.
Eur J Contracept Reprod Health Care. 2024 Apr;29(2):40-52. doi: 10.1080/13625187.2024.2317295. Epub 2024 Mar 1.
[Multiple sclerosis and pregnancy].
Vukusic S, Confavreux C.
Rev Neurol (Paris). 2006 Mar;162(3):299-309. doi: 10.1016/s0035-3787(06)75016-0.
Contraception for women with multiple sclerosis: Guidance for healthcare providers.
Houtchens MK, Zapata LB, Curtis KM, Whiteman MK.
Mult Scler. 2017 May;23(6):757-764. doi: 10.1177/1352458517701314. Epub 2017 Mar 24.
A systematic review and meta-analyses of pregnancy and fetal outcomes in women with multiple sclerosis: a contribution from the IMI2 ConcePTION project.
Lopez-Leon S, Geissbühler Y, Sabidó M, Turkson M, Wahlich C, Morris JK.
J Neurol. 2020 Sep;267(9):2721-2731. doi: 10.1007/s00415-020-09913-1. Epub 2020 May 22.
Pregnancy decision-making in women with multiple sclerosis treated with natalizumab: II: Maternal risks.
Portaccio E, Moiola L, Martinelli V, Annovazzi P, Ghezzi A, Zaffaroni M, Lanzillo R, Brescia Morra V, Rinaldi F, Gallo P, Tortorella C, Paolicelli D, Pozzilli C, De Giglio L, Cavalla P, Cocco E, Marrosu MG, Solaro C, Uccelli A, Laroni A, Pastò L, Giannini M, Trojano M, Comi G, Amato MP; MS Study Group of the Italian Neurological Society.
Neurology. 2018 Mar 6;90(10):e832-e839. doi: 10.1212/WNL.0000000000005068. Epub 2018 Feb 7.
Multiple Sclerosis in Pregnancy: A Commentary on Disease Modification and Symptomatic Drug Therapies.
Iyer P, Dobson R.
Neurol Ther. 2023 Feb;12(1):1-10. doi: 10.1007/s40120-022-00421-0. Epub 2022 Nov 28.
French guidelines on systemic treatments for moderate-to-severe psoriasis in adults: Update 2025.
Masson Regnault M, Brenaut E, Marniquet ME, Berthault C, Canoen L, Marcombes C, Melin A, Ouakrat R, Charles J, Mouret S, Potie O, Penso L, Vegas LP, Larid G, Roux M, Bougeard C, Sylvain S, Labonne C, Randriamiarana T, Pitaud DH, Etheve F, Gottlieb J, Gouillon L, Chastagner M, Sbidian E, Aubert H; Psoriasis Research Group of the French Society of Dermatology (Groupe de Recherche sur le Psoriasis de la Société Française de Dermatologie).
J Eur Acad Dermatol Venereol. 2025 Dec 30. doi: 10.1111/jdv.70263. Online ahead of print.
